EVP-6124 Hepatic Impairment Study

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2014

Conditions
Hepatic Impairment
Interventions
DRUG

Experimental: EVP-6124

Trial Locations (3)

Unknown

Jankovcova 1569/2c, 17000 Praha 7

Ul. Seczkowa 20b/8, Warszawa, Mazowieckie, 02-793

Bardosova 2/A 83101 Bratislava

Sponsors
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

FORUM Pharmaceuticals Inc

INDUSTRY